PowerUp Acquisition: Of The Original Form 8k To Correct The Redemption Price From Approximately $283 Million (approximately $10.51 Per Public Share) To Approximately $284 Million (approximately $10.55 Per Public Share). Except As Set Forth Herein, No Modifications Have Been Made To The Information Contained In The Original Form 8k

Show full article

This functionality is available for registred users only

• Full name
  Aspire Biopharma Holdings Inc
• Registration country
  Cayman Islands
• Industry
  Other Financial Institutions
• М/S&P/F
  *** / *** / ***